Abstract 1594: SMARCA2 (BRM) degraders promotes differentiation and inhibit proliferation in AML models
Year: 2023
Type: conference-abstract
Source: Cancer Research
Institution: Prelude Therapeutics Incorporated (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4362592276
